AU4453301A - Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis - Google Patents

Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis

Info

Publication number: AU4453301A
Authority: AU; Australia
Prior art keywords: spirolaxin; treatment; diseases associated; abnormal angiogenesis; angiogenesis
Prior art date: 2000-03-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU44533/01A

Inventor

Sergio Penco

Claudio Pisano

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sigma Tau Industrie Farmaceutiche Riunite SpA

Original Assignee

Sigma Tau Industrie Farmaceutiche Riunite SpA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-13

Filing date

2001-03-07

Publication date

2001-09-24

2001-03-07 Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA

2001-09-24 Publication of AU4453301A publication Critical patent/AU4453301A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU44533/01A 2000-03-13 2001-03-07 Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis Abandoned AU4453301A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
ITRM200A000129		2000-03-13
IT2000RM000129A IT1317001B1 (en)	2000-03-13	2000-03-13	USE OF SPIROLAXIN FOR THE TREATMENT OF PATHOLOGIES ASSOCIATED WITH AN ALTERED ANGIOGENESIS.
PCT/IT2001/000113 WO2001068070A2 (en)	2000-03-13	2001-03-07	Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis

Publications (1)

Publication Number	Publication Date
AU4453301A true AU4453301A (en)	2001-09-24

Family

ID=11454527

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU44533/01A Abandoned AU4453301A (en)	2000-03-13	2001-03-07	Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis

Country Status (3)

Country	Link
AU (1)	AU4453301A (en)
IT (1)	IT1317001B1 (en)
WO (1)	WO2001068070A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITRM20010136A1 (en) *	2001-03-16	2002-09-16	Sigma Tau Ind Farmaceuti	USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES THAT RESPOND TO THE ACTIVATION OF THE PPAR-GAMMA RECEPTOR.
ITMI20041279A1 (en) *	2004-06-24	2004-09-24	Pharmaproducts Uk Ltd	USE OF TRIFLUOROACETATE CALCIUM FOR THE PREPARATION OF ANTI-ANGIOGENETIC EFFECT MEDICATIONS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996005204A1 (en) *	1994-08-09	1996-02-22	Pfizer Inc.	Spirolaxine derivatives for treating gastroduodenal diseases
JPH107557A (en) *	1996-06-17	1998-01-13	Banyu Pharmaceut Co Ltd	Spirolaxine, an antitumor substance
US6538103B1 (en) *	1998-07-14	2003-03-25	Bristol--Myers Squibb Company	Lysine binding fragments of angiostatin

2000
- 2000-03-13 IT IT2000RM000129A patent/IT1317001B1/en active
2001
- 2001-03-07 AU AU44533/01A patent/AU4453301A/en not_active Abandoned
- 2001-03-07 WO PCT/IT2001/000113 patent/WO2001068070A2/en active Application Filing

Also Published As

Publication number	Publication date
IT1317001B1 (en)	2003-05-26
ITRM20000129A1 (en)	2001-09-13
WO2001068070A8 (en)	2001-11-08
ITRM20000129A0 (en)	2000-03-13
WO2001068070A3 (en)	2002-04-18
WO2001068070A2 (en)	2001-09-20

Similar Documents

Publication	Publication Date	Title
MXPA03002814A (en)	2003-10-14	Morpholin-acetamide derivatives for the treatment of inflammatory diseases.
IL196301A0 (en)	2009-09-22	Medicament for the treatment of hapatitis c
AU2001247331A1 (en)	2001-09-24	Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
HK1061021A1 (en)	2004-09-03	Pyrazole derivatives for the treatment of viral diseases.
AU6910600A (en)	2001-03-19	Methods for the treatment of mental disorders
AU2002210385A1 (en)	2002-04-29	Furazanyl-triazole derivates for the treatment of diseases
AU7622000A (en)	2001-05-10	Compounds for the treatment of viral-mediated diseases
GB0004531D0 (en)	2000-04-19	The treatment of respiratory diseases
AU2001293891A1 (en)	2002-04-15	New combination for the treatment of asthma
HK1051692A1 (en)	2003-08-15	Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
AU2002227895A1 (en)	2002-05-15	Sulphonamides for the treatment of central nervous system diseases
AU2003303217A1 (en)	2004-07-14	Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
AU2002333510A1 (en)	2003-03-18	Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases
AU3004000A (en)	2000-09-14	Methods for the treatment of apolipoprotein e related diseases
ZA200110539B (en)	2003-03-24	Oxazinocarbazoles for the treatment of CNS diseases.
AU4453301A (en)	2001-09-24	Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis
AU3064800A (en)	2000-08-07	The therapeutic use of r-warfarin as anticoagulant
AU1405001A (en)	2001-05-30	Treatment of diseases
AU2002221566A1 (en)	2002-07-01	Novel benzimidazole derivatives for the treatment of gaba-alpha mediated disorders
MXPA03004454A (en)	2003-08-19	Imidazolone derivatives for the treatment of viral diseases.
AU3501100A (en)	2000-09-14	Synergistic combination for treatment of viral-mediated diseases
AU2001262520A1 (en)	2001-12-17	Combined preparation for the treatment of neoplasic diseases
AU2001228863A1 (en)	2001-08-14	Remedies for ophthalmic diseases
AU3071899A (en)	1999-09-20	Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma
AU2000272704A1 (en)	2002-03-26	Use of compounds for the treatment of obesity

Legal Events

Date	Code	Title	Description
2002-03-21	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase